Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-11

FDA Approved: RAXIBACUMAB — Supplemental Application (Emergent Manufacturing Operations Baltimore LLC)

View source ↗

Summary

The FDA approved a supplemental application to support manufacturing operations for the biologic Raxibacumab, submitted by Emergent Manufacturing Operations Bal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raxibacumab (raxibacumab)

Snippet

SUPPL AP for RAXIBACUMAB (RAXIBACUMAB)